Syrma SGS Technology Ltd Q3 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Published 5 Aug 2026 | Industrial Manufacturing | Market Cap: ₹27.7K Cr

The company expects to achieve industry-beating growth of 30-35% in FY '26, continuing momentum from previous quarters. FY '25 EBITDA margin guidance is 7%, targeting approximately ₹305-310 crore EBITDA, with confidence in achieving this. - FY '26 expected growth of 30-35% in revenues, with a corresponding increase in EBITDA margins due to operational leverage. - Management aims to reduce high-volume, low-margin consumer business to below 35% of revenue to improve overall margins. - Industrial, automotive, railway, and other segments expected to contribute higher-margin businesses and revenue growth. - Railways revenue targeted to grow from ₹70 crore in FY '25 to around ₹100 crore+ in FY '26 (approx.

From Syrma SGS Technology Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Price

1,439

Market Cap

₹27.7K Cr

P/E Ratio

74.5

How does Syrma SGS Technology Ltd rank in Industrial Manufacturing?

Compare Syrma SGS Technology Ltd against every Industrial Manufacturing company this quarter on revenue, margins and earnings-call signals.

View Industrial Manufacturing leaderboard →

Syrma SGS Technology Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.5K Cr, net profit ₹119 Cr.

Full financials →

📊 Revenue & Sales Performance

  • The company expects to achieve industry-beating growth of 30-35% in FY '26, continuing momentum from previous quarters.
  • Revenue guidance for FY '25 stands around 4,200-4,500 crores, with potential for marginal variation; target EBITDA margins of 7%+ remain intact.
  • Industrial and automotive segments are growing, with a rising share in the order book; industrial segment expected to expand due to new clients and exports.
  • Railways revenue targeted at around 100 crores in FY '26, up from 70 crores in FY '25, driven by new product approvals.
  • MedTech business is anticipated to rebound with accelerated growth post-FY '26, contributing a reasonable chunk of revenue by FY '26-'27.
  • Exports are targeted to recover and increase back to 25-30% of revenues from current ~20%, especially with the commissioning of Germany facility.
  • Capacity utilization is around 70%, capable of scaling to ~4,000 crores revenue with new facilities like Pune ramping up.
  • High-volume consumer business targeted to reduce to ~35%, enhancing overall margins and growth quality.

📈 Profitability & Margins

  • FY '25 EBITDA margin guidance is 7%, targeting approximately ₹305-310 crore EBITDA, with confidence in achieving this.
  • FY '26 expected growth of 30-35% in revenues, with a corresponding increase in EBITDA margins due to operational leverage.
  • Management aims to reduce high-volume, low-margin consumer business to below 35% of revenue to improve overall margins.
  • Industrial, automotive, railway, and other segments expected to contribute higher-margin businesses and revenue growth.
  • Railways revenue targeted to grow from ₹70 crore in FY '25 to around ₹100 crore+ in FY '26 (approx. 50% growth).
  • MedTech business anticipated to rebound and grow significantly from FY '26 onwards.
  • Export business targeted to increase to 25-30% of revenue over the long term, contributing to higher margins.
  • ROCE is expected to improve, targeting 14.5-15% this year and moving toward 18-20% by FY '27.
  • The company focuses on consistent EBITDA growth rather than just revenue growth, with strategic emphasis on margin improvement.

🏗️ Capital Expenditure Plans

- Current FY 2025 capex: Around Rs. 200 to 245 crore, with an expected spend of Rs. 32 crore in the current quarter (Page 20). - FY 2026 capex: Expected to be around Rs. 100 to 150 crore (Page 20). - Capex primarily towards new campus facility in Pune and a facility in Germany, plus SMT lines and plant & machinery for new customer onboarding (Page 6, 20). - The Pune facility is recently set up; expansion there can be done reasonably quickly to increase capacity for FY 2026-27 (Page 20). - Company evaluating inorganic acquisitions, focusing on design, defense, and other technology-access areas; no deal finalized yet (Page 25). - Considering possible near-shoring to the USA depending on policy developments, which may require strategic capex or acquisitions (Page 25). - QIP approval is in place as a contingency for future growth or acquisitions, but no current plans to raise equity (Page 24-25). These investments align with building sustainable, long-term organizational growth.

💰 Fundraising & Capital Structure

  • The company has board and stakeholder approval for a Qualified Institutional Placement (QIP) but has not initiated it yet; it will only be considered for future growth opportunities, not for existing business working capital needs.
  • The management emphasizes that equity raising is the costliest form of funding and will only be done if a compelling opportunity arises.
  • Currently, there is enough internal accrual to sustain continuous growth without external equity.
  • No current plans for QIP specifically for existing business; any equity raise would be related to inorganic growth or new ventures like OSAT, pending strategy clarity.
  • On debt, the company’s gross debt is about Rs. 685 crore with Rs. 412 crore in treasury (net debt Rs. 273 crore), primarily working capital funded.
  • Continuous efforts are on to reduce working capital days below 60.
  • Capex of Rs. 180 crore spent this year on new facilities; future expansion may require additional capital but no explicit new debt fundraising announced yet.

📋 Order Book & Pipeline

  • As of December 2024, Syrma SGS Technology Limited's open order book visibility is approximately INR 5,300 crores.
  • The order book composition includes:
  • - Over 30% contribution from the auto segment.
  • - Around 38-40% from the consumer segment.
  • - Approximately 20-22% from the industrial segment.
  • - The remaining portion from healthcare, IT, and railway segments.
  • Orders are typically executed over a period of 9 to 15 months.
  • The company has decent order intake in the recent quarter with a solid long-term order book.
  • For the railway segment, the company targets INR 70 crores revenue for the current year and aims for a 50% growth next year (around INR 100 crores+).
  • MedTech segment holds approximately 7-7.5% of total order book visibility; expected to ramp up significantly in FY 26-27.
  • New product approvals, especially in railway and MedTech, are in pipeline, indicating future order growth.

Key Metrics

Frequently Asked Questions

What were Syrma SGS Technology Ltd Q3 FY25 results?

The company expects to achieve industry-beating growth of 30-35% in FY '26, continuing momentum from previous quarters. FY '25 EBITDA margin guidance is 7%, targeting approximately ₹305-310 crore EBITDA, with confidence in achieving this. - FY '26 expected growth of 30-35% in revenues, with a corresponding increase in EBITDA margins due to operational leverage. - Management aims to reduce high-volume, low-margin consumer business to below 35% of revenue to improve overall margins. - Industrial, automotive, railway, and other segments expected to contribute higher-margin businesses and revenue growth. - Railways revenue targeted to grow from ₹70 crore in FY '25 to around ₹100 crore+ in FY '26 (approx.

What is Syrma SGS Technology Ltd share price analysis?

Syrma SGS Technology Ltd currently shows a neutral. The stock trades at a P/E of 74.5 with a market cap of ₹27,654 Cr. Investors should review the full earnings analysis for detailed insights.

Is Syrma SGS Technology Ltd planning capital expenditure?

Current FY 2025 capex: Around Rs.

Keep Syrma SGS Technology Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Industrial Manufacturing this season

  • WPIL (Q3 FY25)

    Domestic: close to INR 400 crores (INR 4,000 million) . Key concall takeaways from WPIL Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Texmaco Rail & Engineering Ltd (Q3 FY25)

    Texmaco Rail & Engineering has an order book of approximately INR 7,600 crores. Key concall takeaways from Texmaco Rail & Engineering Ltd's Q3 FY25 earnings…

  • Praj Industries (Q3 FY25)

    10,000 crores topline. Key concall takeaways from Praj Industries Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Standard Engineering Technology (Q3 FY25)

    During the IPO, order book was around INR 400 crores, and the management confirms good order inflows since then, though specific numbers are not shared. Key…